US stocks fell on Tuesday as weaker-than-expected data on consumer confidence halted investors' demand for equities even after positive earnings news and corporate deals.
Shares of Pfizer Inc fell after the drugmaker said preliminary results of a late-stage study found its experimental "good" cholesterol drug, when combined with its Lipitor drug, raised blood pressure more than in previous studies.
Pfizer slid 2.8 percent to $26.45 and were the top drag on the S&P 500. Shares of Procter & Gamble Co, the consumer goods maker, were one of the biggest drags on the Dow and the S&P 500. The company beat earnings estimates and lifted its profit outlook, but not enough to impress investors.
P&G's shares dropped 1 percent to $63.19. The Dow Jones industrial average was down 40.19 points, or 0.33 percent, at 12,046.31. The Standard & Poor's 500 Index was down 3.13 points, or 0.23 percent, at 1,374.80. The Nasdaq Composite Index was down 2.77 points, or 0.12 percent, at 2,361.
Comments
Comments are closed.